Actively Recruiting
Bone Regeneration Using PRF After Cyst Enucleation
Led by Sana'a University · Updated on 2026-02-20
20
Participants Needed
1
Research Sites
74 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This randomized controlled clinical trial aims to evaluate the clinical efficacy of autologous platelet-rich fibrin (PRF) in promoting osseous regeneration following cystic enucleation in the jaws. The study will assess bone healing outcomes and compare PRF application with conventional management methods.
CONDITIONS
Official Title
Bone Regeneration Using PRF After Cyst Enucleation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with odontogenic cysts requiring surgical enucleation
- Presence of a postoperative bone defect in the jaws after cyst removal
- Age 18 years or older
- Systemically healthy patients classified as ASA I or II
- Patients willing to participate and able to give informed consent
You will not qualify if you...
- Patients with systemic diseases that affect bone healing, such as uncontrolled diabetes or osteoporosis
- Patients receiving bisphosphonates or long-term corticosteroid treatment
- Smokers of more than 10 cigarettes per day
- Pregnant or breastfeeding women
- Patients with acute infection at the surgical site
- Patients unwilling to participate or unable to attend follow-up visits
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Faculty of Medicine and Health Sciences - Sana'a University
Sanaa, Sanaa Governorate, Yemen, 00000
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here